Overall findings in this study and our previous studies (Sabbir, 2018; Sabbir et al., 2020; Sabbir, 2020a) highlights CAMKK2 as a potential therapeutic target for modulating iron homeostasis in neurodegenerative diseases. Here, CAMKK2 is linked to neurodegenerative disease.